Interview: Madhusudhan Venkatachari – CEO, Natco Pharma Canada
Madhu Venkat, CEO of Natco Pharma Canada, highlights the company’s portfolio strategy, its strategic road map to be the first mover and become a leading generic supplier in oncology by…
Natco Pharma (Canada) Inc. is a Canadian subsidiary of Natco Pharma Limited, India. Natco Pharma Limited is a vertically integrated pharmaceutical company heavily focused in R&D and in manufacturing drug intermediates, API and finished formulations. It has a global network and customer centric approach.
The company exports API’s and Formulations to around 50 countries across the globe. Well known for its impressive portfolio of Oncology, Neurology and CNS drugs, it is bringing to market niche pharmaceuticals.
Natco Pharma has been supplying high quality pharmaceuticals to the Canadian market for more than five years, and, since its formation, has set up a very professional Quality, Regulatory, Warehousing, Marketing, Distribution and Logistics capability to service the Canadian market.
The company is slated to launch some of its already approved generic products and in the process of getting approvals for some very niche and very significant pipeline of pharmaceuticals.
Contact:
Address: 2550 Argentina Road, Suite 116, Mississauga, ON, L5N 5R1 Canada
Tel.: +1 (905) 997 3353
Website: http://natcopharma.ca/
Madhu Venkat, CEO of Natco Pharma Canada, highlights the company’s portfolio strategy, its strategic road map to be the first mover and become a leading generic supplier in oncology by…
With a diverse pipeline to back up its projects, Tetra Bio-Pharma wants to be the first Canadian pharmaceutical company to launch a cannabis-based drug in breakthrough pain. Bernard Fortier, CEO…
Heading Canada’s largest cannabis Business to Business Retailer, John Fowler, CEO of The Supreme Cannabis Company, offers a novel approach looking at medical cannabis as a medicine that is not…
Several smaller pharmaceutical companies – Taiho, Valneva, Mallinckrodt, Théa and Intercept Pharma – have chosen to set up operations in Canada very recently, recognizing the potential for product launches and development…
Despite Canada’s provincial approach to healthcare, Steve Gundersen, president of BD Canada’s operations, praises the collaborative spirit of healthcare stakeholders at all levels in order to overcome the challenges, such…
Red Leaf Medical, founded in 2009, is unique in its approach to the Canadian healthcare market, being the only company focused exclusively on urology solutions. Charles Ko, managing director, discusses…
Marc Wayne, serial entrepreneur and a pioneer within the field of medical cannabis discusses his dedication to the field, how cannabis-based therapies have the potential to disrupt the pharmaceutical industry…
Warren Bravo, co-founder and CEO of Green Relief, speaks about the company’s unique growing technique – aquaponics – which allows it to produce ‘better than organic’ medical cannabis. He gives…
Specializing on products adapted to the needs of seniors and long-term care patients, WeedMD is scaling up its production capacity to better meet the needs of this particular patient group…
Panalpina’s Dimitri Brink speaks about the main highlights of his first two years of tenure in the Canadian affiliate and how he brought the fully closed GDP (good distribution practices)…
Frank Baylis, chairman of the board at Baylis shares his views on his motivations for maintaining a lifelong interest in healthcare, the Baylis approach to problem solving, and sharing knowledge…
Moving into the position of National Pharma & Life Sciences Leader, PwC’s Rami El-Cheikh announces the firm’s plan to introduce the comprehensive Pharma Advisory Services currently existing in the US…
John Simmons, VP Sales & Marketing (Health Systems) at Philips Canada talks about the company’s commitment to delivering integrated health technology solutions that provide continuous care across the health continuum.…
See our Cookie Privacy Policy Here
